Sponsor pipeline

Anhui Provincial Hospital clinical trial pipeline

Get alerts when Anhui Provincial Hospital's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-21

What changed in the last 30 days

2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.

Show 1 trial with minor changes only
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-09-25 NCT07841873 Zanidatamab Combined With Liposomal Irinotecan and Capecitabine for Second-line Treatment… Phase 2 Not Yet Recruiting
2026-09-21 NCT07830576 Multimodal Survival Prediction Model for Colorectal Liver Metastases Post-Operation Recruiting

Active trials by phase

Early Phase 1
7
Phase 1
9
Phase 1/2
2
Phase 2
12
Phase 3
4
Phase 4
3
Not charted: 34 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 23

Liver Cancer (9) · Esophageal Cancer (8) · Cervical Cancer (7) · Leukemia (5) · Lung Cancer (4) · Prostate Cancer (4) · Colorectal Cancer (3) · Ovarian Cancer (3) · Acute Lymphoblastic Leukemia (ALL) (2) · Cholangiocarcinoma (2)

Get alerts when Anhui Provincial Hospital's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free